Ketamine is a compound used for treating depression, suicidality, and PTSD, but it is also commonly abused. This podcast discusses its clinical benefits, risks, mechanisms of action, and ability to produce dissociative states. It covers dosage, delivery routes, and long-term changes in the brain. The concept of neuroplasticity and the role of brain-derived neurotrophic factor (BDNF) in learning and memory are also explored. Ketamine has established clinical uses in the treatment of depression, suicidality, and PTSD, but it also has a high potential for abuse and is used recreationally. The increased accessibility of ketamine has led to a rise in recreational use. Ketamine induces a dissociative state similar to dreaming, sought after for therapeutic purposes, but recreational use can lead to unpredictable effects and unpleasant experiences. Ketamine has significant benefits in treating depression, suicidality, and associated feelings of helplessness and worthlessness. Its antidepressant effects are short-lived, lasting only about three days to a week, but sustained relief can be achieved with twice-weekly treatments for three weeks. Ketamine likely acts through multiple mechanisms to provide relief from depression, including inducing relief quickly, providing relief in the days and weeks following treatment, and inducing long-lasting changes in the nervous system. The relief provided by ketamine is not solely due to NMDA receptor blockade, as the opioid receptor pathway is also involved. Ketamine therapy can shift the brain's system towards further neural circuit changes in response to daily activities, ultimately improving mental health. Ketamine induces dissociative states, alters brain circuits, and impacts brain waves associated with dissociative states. It provides short-term relief from depression, but sustained changes and durable effects require multiple treatments over several weeks to induce neuroplasticity and rewiring of brain circuits.
Ketamine
Ketamine is a compound used for treating depression, suicidality, and PTSD, but it is also commonly abused. This podcast discusses its clinical benefits, risks, mechanisms of action, and ability to produce dissociative states. It covers dosage, delivery routes, and long-term changes in the brain. The concept of neuroplasticity and the role of brain-derived neurotrophic factor (BDNF) in learning and memory are also explored.
- Ketamine is used clinically for depression, suicidality, and PTSD
- It is commonly abused
- Mechanisms of action and ability to produce dissociative states
- Dosage and delivery routes
- Long-term changes in the brain
- Neuroplasticity and the role of BDNF in learning and memory
Ketamine & PCP; Clinical & Recreational Use
- Ketamine and PCP have similar modes of action in the brain.
- Ketamine is known for its clinical benefits in treating depression, suicidality, and PTSD.
- Ketamine also has a high potential for abuse and is used recreationally at parties.
- Recreational use of ketamine can lead to a state called "k-holes."
- Despite its potential dangers, ketamine is considered an incredible drug with crossover between its clinical and recreational uses.
- Ketamine has seen a shift in its perception and use in recent years.
- Ketamine has established clinical uses in the treatment of depression, suicidality, and PTSD.
- The increased accessibility of ketamine has led to a rise in recreational use.
- The potential for abuse should not overshadow the therapeutic benefits of ketamine.
Depression & Current Treatments
Depression & Current Treatments:
The monoamine hypothesis of depression, which suggests deficiencies in neurotransmitters like serotonin, dopamine, and norepinephrine lead to depression, lacks evidence. Drugs like Prozac and Zoloft, which increase these monoamines, only work in about 40% of depressed individuals and often have side effects.
Ketamine, a dissociative anesthetic, is being explored as a potential treatment for depression due to its ability to provide relief without side effects. It can induce a transitional state between wakefulness and sleep.
Ketamine is used for the treatment of depression, suicidality, and PTSD. It induces a dissociative state similar to dreaming, sought after for therapeutic purposes. However, recreational use can lead to unpredictable effects and unpleasant experiences. The effects of ketamine vary depending on dosage and delivery route.
Preclinical Models of Depression & Ketamine; “Learned Helplessness”
The preclinical model of learned helplessness involves observing how long rats or mice swim to save themselves, providing insights into depression. Researchers use this model to study depression in animals and test different drugs. One surprising finding is that low doses of ketamine, an NMDA receptor blocker, can prolong the duration of the animal's attempt to save itself. This contradicts the expected effects of ketamine and has led to further studies on its antidepressant effects in depressed patients.
Ketamine & Clinical Uses; Depression & Suicidality
Ketamine, a dissociative anesthetic, has shown potential for treating depression by providing rapid relief within minutes of administration. Its antidepressant effects are short-lived, but it is effective for individuals who do not respond to other treatments. Key points include:
- In the early 2000s, ketamine was explored as a treatment for depression that did not respond to traditional drugs like Prozac.
- A landmark study found that intravenous injections of half a milligram per kilogram of body weight of ketamine resulted in rapid antidepressant effects without inducing deep anesthesia.
- Ketamine induces a euphoric and dissociative state, providing immediate relief from depression that lasts for several days.
- Traditional antidepressant drugs often take weeks or months to show effects, making ketamine's rapid relief valuable for individuals suffering from depression.
- Ketamine has significant benefits in treating depression, suicidality, and associated feelings of helplessness and worthlessness.
- It is particularly effective for individuals who do not respond to other forms of depression treatment.
Ketamine & Other Psychiatric Challenges; Relief & Durability
Ketamine has shown to be effective in treating various psychiatric challenges, including major depression, bipolar depression, PTSD, OCD, anxiety, and substance addiction. However, its antidepressant effects are short-lived, lasting only about three days to a week. This creates challenges as people may need to take ketamine every week, but its dissociative effects and potential for abuse make this impractical.
To address this, studies have explored the use of ketamine twice per week for three weeks, which has shown sustained relief from depression throughout the duration. When administered in this dosing regimen, ketamine provides immediate relief from depressive symptoms and continues to provide relief in the days and weeks following treatment. This sustained relief can last for months.
Ketamine likely acts through multiple mechanisms to provide relief from depression. These mechanisms include inducing relief quickly, providing relief in the days and weeks following treatment, and inducing long-lasting changes in the nervous system. Understanding these mechanisms can help shed light on the neural circuitry underlying depression and how relief from depression is achieved through neuroplasticity.
Key points:
- Ketamine is effective in treating major depression, bipolar depression, PTSD, OCD, anxiety, and substance addiction.
- Its antidepressant effects are short-lived, lasting only about three days to a week.
- The dissociative effects and potential for abuse make frequent ketamine use impractical.
- Studies have explored the use of ketamine twice per week for three weeks, which has shown sustained relief from depression.
- Ketamine provides immediate relief from depressive symptoms and continues to provide relief in the days and weeks following treatment.
- This sustained relief can last for months.
- Ketamine likely acts through multiple mechanisms to provide relief from depression, including inducing relief quickly, providing relief in the days and weeks following treatment, and inducing long-lasting changes in the nervous system.
NMDA Receptor & Neuroplasticity
Ketamine blocks the NMDA receptor, critical for neuroplasticity.
- NMDA receptor binds glutamate, an excitatory neurotransmitter.
- Ketamine easily crosses the blood-brain barrier.
- NMDA receptor requires both chemical A and B for neuroplasticity.
The NMDA receptor responds to high levels of glutamate and electrical activity.
- Glutamate and NMDA receptor involved in motor coordination.
- Unusually high levels of activity detected by neurons.
- Typical activity involves glutamate binding to AMPA receptors.
NMDA receptor activation triggers intracellular processes for neuroplasticity.
- Increase in glutamate leads to changes in the nervous system.
- Activation recruits other glutamate receptors to the cell surface.
- Gene expression and introduction of new receptors occur.
NMDA receptor strengthens and grows neural connections for neuroplasticity.
- Similar to muscles growing stronger with exercise.
- Once connections are formed, they can be maintained without repeated stimulation.
Excitatory & Inhibitory Communication, Seizure, NMDA Receptors & Ketamine
The role of NMDA receptors in neuroplasticity and the effects of ketamine on transitioning from a depressed state to a non-depressed state are discussed. The key points are:
- Excitatory neurons release glutamate, activating other neurons, while inhibitory neurons release GABA, reducing electrical activity.
- Seizures occur due to an imbalance between excitatory and inhibitory neurons.
- Inhibitory neurons suppress activity to prevent seizures, while excitatory neurons stimulate activity.
- Ketamine, an NMDA receptor antagonist, paradoxically increases neuroplasticity in mood and reward circuits.
- Ketamine binds to NMDA receptors on inhibitory neurons, reducing inhibition and increasing excitatory activity.
- This leads to bursting patterns of electrical activity, inducing long-term changes in mood-related neural circuits.
- Ketamine's effects on these circuits are relevant to relieving symptoms of major depression.
How Ketamine Functions in Brain; Acute & Long-Term Effects
Ketamine functions by binding to the NMDA receptor in the brain, blocking its typical function of recruiting changes to cells and receptors in response to neural activity. This prevents the normal process of neuroplasticity, where neurons change and strengthen in response to experience.
Key points:
- Ketamine induces neuroplasticity in mood-related brain circuits by blocking NMDA receptors on inhibitory neurons.
- This increases excitatory communication between neurons, strengthening connections and improving mood.
- Ketamine does not induce seizures, but rather creates changes in neural circuits associated with positive mood and reduces negative mood.
- The process of ketamine creating neuroplasticity takes many days and involves changes in gene expression and the creation of new proteins and receptors.
- The NMDA receptor blockade is critical for the long-term changes in mood associated with ketamine therapy for depression.
- The immediate effects of ketamine, such as dissociation and euphoria, may also be influenced by NMDA receptor blockade.
- The durability of ketamine's effects is likely due to the rewiring of neural circuits.
Brain-Derived Neurotrophic Factor (BDNF) & Ketamine Therapy
Brain-Derived Neurotrophic Factor (BDNF) & Ketamine Therapy Summary:
- BDNF plays a crucial role in neuroplasticity, triggering the growth of new branches on neurons and acting as a neurotransmitter.
- Ketamine treatment for depression induces the release of BDNF, making neural circuits more plastic and improving mood.
- Studies show that ketamine's antidepressant effects are dependent on the presence of BDNF.
- Ketamine binds to the BDNF receptor, suggesting it can mimic the effects of BDNF in the brain.
- Ketamine therapy for depression works by acting as a growth factor or mimicking the action of growth factors, allowing specific neural circuits related to mood to change.
- Ketamine suppresses NMDA receptors, causing burst activity in mood-related circuits and releasing BDNF, leading to immediate and long-term relief for depression.
Ketamine & Opioid Pathway
Ketamine, a drug that induces neuroplasticity and improves mood for depression, also binds to opioid receptors in the brain and body. This binding can lead to pain relief, mood changes, and even euphoria. The specific opioid receptors that ketamine targets are the MU opioid receptor and the Kappa opioid receptor. Interestingly, the dosage of ketamine used for depression relief is lower than the dosage that induces dissociative and euphoric states. Researchers are investigating whether the effects of ketamine on depression are due to changes in the glutamate system or the opioid system. A study at Stanford School of Medicine found that blocking the opioid receptor pathway eliminated the antidepressant effects of ketamine, suggesting that the opioid system is responsible for its therapeutic effects. The metabolite hydroxy nor ketamine may be the mechanism through which ketamine relieves depression.
Divergent Mechanisms of Immediate & Long-Term Effects
Ketamine and other drugs have both immediate and long-term effects on depression and other mental health conditions. The relief experienced while under the influence of these drugs may not directly cause the improvement in symptoms, but instead trigger various processes in the brain. These processes rely on receptors like the opioid receptor pathway and neuroplasticity, leading to immediate, short-term, and long-lasting changes. It is important to consider both the acute and post-acute effects of these drugs and to understand the interconnectedness of drug effects and other factors in treating depression.
Habenula, Pro-Depressive Behaviors & Ketamine Therapy
Ketamine therapy has positive effects on depressive symptoms by modulating the activity of the habenula and its connections. The habenula inhibits the reward pathway, but ketamine reduces this inhibition, making the reward pathway more available. However, the changes in neural circuits from ketamine are only effective if reinforced by pro-depressive behaviors. Individuals need to engage in stimulating work, social engagement, and take care of mental and physical health. Ketamine therapy can shift the brain's system towards further neural circuit changes in response to daily activities, ultimately improving mental health.
Ketamine & Context-Dependent Strategy; Reward Pathway
Ketamine treatment for depression and PTSD reduces habenula output to the reward pathway, increasing engagement in anti-depressive thoughts and behaviors. It enhances neuroplasticity in reward pathway connections with the frontal cortex, crucial for context-dependent strategy building. Ketamine improves connectivity between brain areas associated with strategy building and reward pathways, increasing sensitivity to results and ability to adjust efforts. The relief provided by ketamine is not solely due to NMDA receptor blockade, as memantine has no antidepressant effects.
Dissociative States
Ketamine induces dissociative states, where individuals feel separate from their body and observe themselves from a third-person perspective. This is also a symptom of PTSD and trauma. The drug causes neuroplastic changes and alters the MU opioid receptor system, potentially explaining its effectiveness in treating depression. Ketamine uncouples neocortical brain circuits, leading to a different dominant rhythm in the brain. It abolishes the alpha pattern of activity and unveils the theta pattern, associated with a liminal state between wakefulness and sleep. The effects of ketamine typically last for about one to two hours.
Doses & Routes of Administration; “K-holes”; Risk & Caution
Ketamine can be taken through different routes of administration, including intravenous or intramuscular injection, oral ingestion, or sublingual administration. However, only a fraction of orally or sublingually taken ketamine reaches the bloodstream and acts on the brain, requiring higher doses to achieve the same effects as injection. The term "k-hole" refers to the subjective experience of being in a pseudo-anesthetized state due to a higher dose of ketamine. Ketamine can be dangerous if taken at high doses, leading to full-blown anesthesia and potentially deadly consequences, especially when combined with other drugs. It is important to be cautious when using ketamine, as it can cause deep unconsciousness and even death. Driving or engaging in activities that require alertness should be avoided while under the influence of ketamine. Ketamine can also induce seizures, particularly in individuals who are prone to seizures due to epilepsy or prior head injury.
Ketamine Forms; R-, S- vs R/S- Ketamine; Micro-Dosing
Ketamine Forms; R-, S- vs R/S- Ketamine; Micro-Dosing
Ketamine comes in different forms and can be administered through various routes such as intranasal, oral, sublingual, and rectal. Rectal administration is sometimes preferred to avoid liver damage. The S form of ketamine appears to be more potent in binding to the NMDA receptor based on clinical data and binding studies.
- Ketamine comes in different forms and can be administered through various routes such as intranasal, oral, sublingual, and rectal.
- Rectal administration is sometimes preferred to avoid liver damage.
- The S form of ketamine appears to be more potent in binding to the NMDA receptor based on clinical data and binding studies.
- The combined Sr form of ketamine is the most potent in relieving depressive symptoms, followed by the S form of ketamine.
- The pure R form of ketamine is the least effective in treating depression.
- Microdosing ketamine has not been proven to be effective for treating depression.
- The positive effects on depression have been observed in studies where a higher dosage of ketamine was used.
- Currently, there is no published clinical evidence supporting the benefits of microdosing ketamine for depression.
Ketamine: Effects & Therapy
Ketamine is a compound that blocks the NMDA receptor, leading to dissociation and mild euphoria at low doses, and anesthesia and subconscious states at higher doses. It has potential risks such as seizures and death if the dosage is too high. Ketamine's antidepressant effects are believed to be related to the activation of the BDNF molecule and the involvement of the opioid receptor system. It impacts brain circuits and brain waves associated with dissociative states and provides short-term relief from depression. However, sustained changes and durable effects require multiple treatments over several weeks to induce neuroplasticity and rewiring of brain circuits. Engaging in anti-depressive behaviors alongside ketamine treatment is important for optimal results.
Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network Newsletter
The most profound aspect of the topic is the discussion on ways to support the podcast and the host's gratitude towards the viewers' interest in science.
Key points:
- The video discusses ways to support the podcast, such as subscribing to the YouTube channel and leaving reviews on Spotify and Apple.
- The podcast mentions its partnership with Momentous supplements and encourages listeners to check out the sponsors.
- The host is present on social media platforms where he covers science-related topics.
- The podcast offers a free monthly newsletter called the Neural Network Newsletter, which includes podcast summaries and protocols for various topics.
- The host expresses gratitude towards the viewers for their interest in science.